risers & fallers – 07/02/14
Risers:
Proteome Sciences +12.93%
Shares in Proteome Sciences are up over 12% this morning after the protein and peptide specialist revealed they expect full year revenue to be substantially higher than last year. The company also reported on its interest in biomarker services, saying: ”We are pleased to announce that we have signed the term sheet for a biomarker services contract to process a large cohort of patient samples from which we aim to develop a companion diagnostic”.
Greka Drilling +24.09%
Greka Drilling has announced they know of no reason why its share price has recently dropped. In the statement, the gas field drilling company said they have had a strong start to 2014, winning various contracts and also ‘de-risked’ the company by increasing their geographical spread throughout India. The company summed this up by saying: “As such, the company sees no reason for the decline of the share price given the visibility of increased revenues for 2014.”
Fallers:
Shire -0.81%
Shire has today abandoned its research on its hyperactivity drug, Vyvanse, to see whether it could be used to deal with depression. This comes after the company revealed two of its trials failed to show the drug had any effect in treating depression. Commenting on the drug, Chief Executive Flemming Ornskov has said: “While this news in major depressive disorder is disappointing for patients and Shire, we will later in the year be filing with the FDA [U.S. Food & Drug Administration] for a new indication for Vyvanse in binge eating disorder in adults”.
Trinity Exploration & Production PLC -10.00%
Trinity Exploration & Production PLC has announced its 70% owned El Dorado well is set to be abandoned. The company has made this decision after drilling 6174 feet found non-commercial production levels.
Auhua Clean Energy -3.61%
Shares in Auhua Clean Energy are down today despite the company revealing it expects a 16.4% increase in full year revenue. Full year results are set to be announced around the end of April 2014.
Comments (0)